World Day

Meningitis: 1.8 million very young children are still ‘unvaccinated’

From very young children to teenagers who ‘suffer’ the consequences of fluctuating regional policies: paediatricians sound the alarm as they take stock of the figures that need to be improved

 ANSA/ TIZIANO MANZONI ANSA

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

‘Almost 1.8 million children and young people who are unvaccinated or have not been fully vaccinated represent a very large group where we can still take action. It is important to check your children’s vaccination status and catch up on any missing doses. Meningococcal meningitis can, in fact, progress very rapidly and have extremely serious consequences.’ Thus, Rino Agostiniani, president of the Italian Paediatric Society (SIP), has sounded the alarm over the lack of or inadequate vaccination coverage for one of the most insidious diseases – one which can, however, be prevented through prophylaxis and is fully included in the National Immunisation Schedule.

Paediatricians have issued this warning to mark World AIDS Day, in light of figures that indicate there is significant room for improvement. The analysis confirming that 1,780,545 individuals are inadequately protected was carried out by cross-referencing Istat data on birth cohorts from 2014 to 2022 with the Ministry of Health’s currently available data on vaccination coverage at 24 months

Loading...

Meningococcal meningitis: it can develop within a few hours

Meningococcal meningitis is an inflammation of the membranes surrounding the brain and spinal cord caused by the bacterium Neisseria meningitidis. The bacterium is transmitted through saliva and respiratory secretions during close contact. Many people may be carriers without developing the disease, but in some cases the bacterium can cause an invasive disease, which may present as meningitis and/or sepsis.

The course of the disease can be very rapid: even when the illness is diagnosed and treated promptly, in the most severe cases it can lead to death within 24–48 hours. Meningococcal meningitis can be fatal in 5–10 per cent of cases and cause serious complications in 10–20 per cent of survivors, including neurological deficits, hearing loss, blindness and other permanent disabilities.

MenB: catching up on missed doses and bridging regional disparities

The current National Vaccination Prevention Plan provides for the active and free provision of the meningococcal B vaccine to children from the age of 3 months. However, the SIP believes it is necessary to step up catch-up vaccination programmes, as there remains a very high number of children and young people who are unvaccinated or have an incomplete vaccination course.

Focus on teenagers

Particular attention must be paid to adolescents, who – due to the greater frequency of their social contacts – represent, after young children in their early years, the second age group most at risk of contracting meningococcal B meningitis. ‘In this age group, however, vaccination coverage remains inconsistent across the regions,’ emphasises Rocco Russo, coordinator of the SIP Technical Committee on Vaccinations. “There are regions that vaccinate only adolescents who have never been vaccinated, others that also include those vaccinated during childhood, and still others that do not provide any vaccination at all. It is important to achieve a uniform vaccination programme across the whole country, prioritising adequate protection for those who have never been vaccinated.”

There is not just one type of meningococcus

There are several serogroups of Neisseria meningitidis. In addition to serogroup B, the serogroups most commonly responsible for the disease include A, C, W-135 and Y. A quadrivalent MenACWY vaccine is available for these four serogroups: the current National Vaccination Programme recommends one dose from the age of 12, both for adolescents who have never been vaccinated before and for those who were previously immunised with MenC during childhood. Protection against meningococcal disease is therefore provided at different stages of childhood and adolescence, in accordance with the specific preventive strategies set out.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti